Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3Lymphoid 1

Conditions

Pneumonia, Pneumococcal 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1

Interventions

Cyclophosphamide 59fludarabine phosphate 52Peripheral Blood Stem Cell Transplantation 40Busulfan 39Tacrolimus 35Antilymphocyte Serum 34Mycophenolic Acid 33Radiotherapy 30Filgrastim 28Cyclosporine 25Melphalan 24Methotrexate 22Whole-Body Irradiation 21fludarabine 20Methylprednisolone 17Etoposide 16Cord Blood Stem Cell Transplantation 15sargramostim 9Rituximab 9Granulocyte Colony-Stimulating Factor 9Cytarabine 9Bortezomib 9Alemtuzumab 9Sirolimus 8Epoetin Alfa 7Psychiatric Rehabilitation 6Prednisone 6Flow Cytometry 6Carmustine 6Trimethoprim, Sulfamethoxazole Drug Combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Heptavalent Pneumococcal Conjugate Vaccine × Lymphoid × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡